Furthermore, NK cells present in the tumor of Caspase-1-deficient hosts expressed higher levels of NK cell activation markers NKG2D, Granzyme B (GZB), CD69 and CD98 (Figure 6D) (42). This evidence concerns the gene KLRK1 and neoplasm.